Chronic inflammatory demyelinating polyneuropathy with an acute onset. Clinical case [PDF]
Терапевтический архив, 2022 Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous treatable dysimmune neuropathy. The variety of clinical forms and course of the disease can be challenging for proper diagnosis and early treatment.
Natalia A. Suponeva +5 more
doaj +3 more sources
Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19
Düzce Tıp Fakültesi Dergisi, 2022 The cases of Guillain Barre Syndrome (GBS) have been reported following the coronavirus disease 2019 (COVID-19). Here, we describe a case that evolved from GBS to chronic inflammatory demyelinating polyneuropathy (CIDP) after COVID-19 in terms of ...
Nilgün Çınar +4 more
doaj +4 more sources
Acute Inflammatory Demyelinating Polyneuropathy and a Unilateral Babinski/Plantar Reflex [PDF]
Anesthesiology Research and Practice, 2008 Acquired acute demyelinating peripheral polyneuropathy (AADP) is a general classification of pathologies that could affect secondary the peripheral nervous system. They are characterized by an autoimmune process directed towards myelin.
Davide Cattano +4 more
doaj +5 more sources
Acute Inflammatory Demyelinating Polyneuropathy: a comprehensive literature review
Journal of Education, Health and SportIntroduction and purpose Guillain-Barré Syndrome (GBS) is an acute, immune-mediated polyneuropathy characterized by rapid-onset muscle weakness and areflexia.
Karolina Serwońska +8 more
doaj +2 more sources
Acute onset chronic inflammatory demyelinating polyneuropathy with prostatic malignancy
Annals of Indian Academy of Neurology, 2021 Puja Rani +3 more
doaj +3 more sources
Complication of Hepatitis A Infection: Case Report of Acute Inflammatory Demyelinating Polyneuropathy. [PDF]
Clin Pract Cases Emerg Med, 2021 Acute inflammatory demyelinating polyneuropathy (AIDP) is characterized by progressive, mild sensory symptoms and progressive areflexic weakness. It typically follows a gastrointestinal or respiratory infection but has rarely been described after acute viral hepatitis.This is the case of a 59-year-old male who presented to the emergency department ...
Laursen D, Krug J, Wolford R.
europepmc +7 more sources
Tubercular Meningitis with Acute Inflammatory Demyelinating Polyneuropathy-Trigger or Chance. [PDF]
J Neurosci Rural Pract, 2019 AbstractTuberculosis being a global pandemic causes an array of neurological presentations ranging from tuberculoma, meningitis, radiculomyelitis, brain abscess, and so on.Association of Guillain-Barre syndrome with tuberculosis has been reported five to six times in the past.
Dalai SP, Kabi S, Arve NR, Kakollu VR.
europepmc +4 more sources
Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy. [PDF]
Cureus, 2018 Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use.
Manam R +6 more
europepmc +4 more sources
Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study. [PDF]
J Peripher Nerv SystABSTRACT Background and Aims Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an immune‐mediated neuropathy that may cause persistent disability despite immunoglobulin treatment. Ion channel dysfunction has been demonstrated in CIDP, but no therapies specifically target this mechanism.
Hansen PN +5 more
europepmc +2 more sources
Biomarkers of ‘acute-onset’ chronic inflammatory demyelinating polyneuropathy [PDF]
Brain, 2014 Sir, We read with great interest the article by Sung et al. (2014) reporting the usefulness of nerve excitability testing in differentiating acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) from acute inflammatory demyelinating polyneuropathy (AIDP).
Yumako, Miura +2 more
openaire +2 more sources